AcelRx Pharma readies stock offering; shares down 14% premarket

|About: AcelRx Pharmaceuticals... (ACRX)|By:, SA News Editor

AcelRx Pharmaceuticals (NASDAQ:ACRX) slumps 14% premarket on light volume in reaction to its planned stock offering. Price, volume and terms have yet to be announced.

Subscribe for full text news in your inbox